The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

19 articles for S Ninkovic


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors.EBI
Pfizer
Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3Ka and mTOR.EBI
Pfizer
Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrEBI
Pfizer
Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors.EBI
Pfizer
4-methylpteridinones as orally active and selective PI3K/mTOR dual inhibitors.EBI
Pfizer
Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1.EBI
Pfizer
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer.EBI
Pfizer
Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain.EBI
Pfizer
ACRYLAMIDE COMPOUNDSBDB
NRG Therapeutics
ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 (ENPP1) INHIBITORS AND USES THEREOFBDB
Insilico Medicine IP
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBDB
Bayer Aktiengesellschaft
Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitorsBDB
Incyte
Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitorsBDB
Bayer Pharma Aktiengesellschaft
Dihydropyrrolopyridine inhibitors of ROR-gammaBDB
Vitae Pharmaceuticals
Conjugate comprising a neurotensin receptor ligand and use thereofBDB
3B Pharmaceuticals
Heteroaryl compounds and uses thereofBDB
Celgene Car
Inhibitors of the renal outer medullary potassium channelBDB
Merck Sharp & Dohme
The preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors containing a but-(2E)-en-1,4-diyl connecting linkage.BDB
University of Defence
Heterocyclic compoundsBDB
Shionogi